These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 17449089)
21. Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants? Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandalà M; Papaldo P; Fabi A; Ciccarese M; Cuppone F; Cecere FL; Nuzzo C; Terzoli E; Cognetti F Chest; 2006 Dec; 130(6):1808-16. PubMed ID: 17167001 [TBL] [Abstract][Full Text] [Related]
22. Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study. Lacherade JC; Cook D; Heyland D; Chrusch C; Brochard L; Brun-Buisson C; J Crit Care; 2003 Dec; 18(4):228-37. PubMed ID: 14691896 [TBL] [Abstract][Full Text] [Related]
23. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival. Nishioka J; Goodin S J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108 [TBL] [Abstract][Full Text] [Related]
24. Prophylaxis against venous thromboembolism in orthopedic surgery. Liu LT; Ma BT Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000 [TBL] [Abstract][Full Text] [Related]
25. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients. Deitelzweig SB; Vanscoy GJ; Niccolai CS; Rihn TL Ann Pharmacother; 2003 Mar; 37(3):402-11. PubMed ID: 12639173 [TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery. Dainty L; Maxwell GL; Clarke-Pearson DL; Myers ER Gynecol Oncol; 2004 May; 93(2):366-73. PubMed ID: 15099947 [TBL] [Abstract][Full Text] [Related]
28. Thromboembolic prophylaxis in head trauma and multiple-trauma patients. Latronico N; Berardino M Minerva Anestesiol; 2008 Oct; 74(10):543-8. PubMed ID: 18475247 [TBL] [Abstract][Full Text] [Related]
29. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038 [TBL] [Abstract][Full Text] [Related]
30. Venous thromboembolism following gynaecological surgery for suspected or confirmed malignancy. Hitos K; Wain GV; Fletcher JP Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):23-7. PubMed ID: 21951130 [TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery. Maxwell GL; Myers ER; Clarke-Pearson DL Obstet Gynecol; 2000 Feb; 95(2):206-14. PubMed ID: 10674581 [TBL] [Abstract][Full Text] [Related]
32. Heparin for venous thromboembolism prophylaxis in patients with acute spinal cord injury: a systematic review and meta-analysis. Chen HL; Wang XD Spinal Cord; 2013 Aug; 51(8):596-602. PubMed ID: 23689387 [TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. Clarke-Pearson DL; Coleman RE; Synan IS; Hinshaw W; Creasman WT Am J Obstet Gynecol; 1983 Mar; 145(5):606-13. PubMed ID: 6338722 [TBL] [Abstract][Full Text] [Related]
35. Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update. Falciani M; Imberti D; Prisco D Intern Emerg Med; 2006; 1(4):273-8. PubMed ID: 17217148 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of pre-operative pharmacologic thromboprophylaxis on incidence of venous thromboembolism following major gynecologic and gynecologic oncology surgery: a systematic review and meta-analysis. Bisch S; Findley R; Ince C; Nardell M; Nelson G Int J Gynecol Cancer; 2021 Feb; 31(2):257-264. PubMed ID: 33214216 [TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Schmeler KM; Wilson GL; Cain K; Munsell MF; Ramirez PT; Soliman PT; Nick AM; Frumovitz M; Coleman RL; Kroll MH; Levenback CF Gynecol Oncol; 2013 Feb; 128(2):204-8. PubMed ID: 23200912 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of the use of heparin as thromboprophylaxis in patients with liver cirrhosis: a systematic review and meta-analysis. Gómez Cuervo C; Bisbal Pardo O; Pérez-Jacoiste Asín MA Thromb Res; 2013 Oct; 132(4):414-9. PubMed ID: 23993900 [TBL] [Abstract][Full Text] [Related]
39. A comparison of thromboembolic prophylaxis in gynecologic oncology patients. Ailawadi M; Del Priore G Int J Gynecol Cancer; 2001; 11(5):354-8. PubMed ID: 11737465 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of intermittent pneumatic compression for venous thromboembolism prophylaxis in patients undergoing gynecologic surgery: A systematic review and meta-analysis. Feng JP; Xiong YT; Fan ZQ; Yan LJ; Wang JY; Gu ZJ Oncotarget; 2017 Mar; 8(12):20371-20379. PubMed ID: 27901494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]